Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673585 | SCV000798805 | likely pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2018-03-30 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000673585 | SCV004199909 | likely pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2023-11-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000673585 | SCV004511718 | pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2023-11-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr176*) in the HMGCL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMGCL are known to be pathogenic (PMID: 9817922, 17692550, 23465862). This variant is present in population databases (rs112508527, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with HMGCL-related conditions. ClinVar contains an entry for this variant (Variation ID: 557442). For these reasons, this variant has been classified as Pathogenic. |